CN112933182A - 一种治疗白发的综合药物及其制备方法 - Google Patents
一种治疗白发的综合药物及其制备方法 Download PDFInfo
- Publication number
- CN112933182A CN112933182A CN202110433501.9A CN202110433501A CN112933182A CN 112933182 A CN112933182 A CN 112933182A CN 202110433501 A CN202110433501 A CN 202110433501A CN 112933182 A CN112933182 A CN 112933182A
- Authority
- CN
- China
- Prior art keywords
- heating
- treating
- root
- medicine
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 210000004209 hair Anatomy 0.000 title claims description 38
- 238000010438 heat treatment Methods 0.000 claims description 18
- 241000906988 Ganoderma atrum Species 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 240000000249 Morus alba Species 0.000 claims description 11
- 235000008708 Morus alba Nutrition 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 10
- 244000235659 Rubus idaeus Species 0.000 claims description 10
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 10
- 239000010935 stainless steel Substances 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 7
- 244000223014 Syzygium aromaticum Species 0.000 claims description 7
- 241001313857 Bletilla striata Species 0.000 claims description 6
- 240000000691 Houttuynia cordata Species 0.000 claims description 6
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 6
- 229940107131 ginseng root Drugs 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 244000110343 Elephantopus scaber Species 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000005746 Ruta graveolens Species 0.000 claims description 4
- 235000001347 Ruta graveolens Nutrition 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000001229 ruta graveolens Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 241001289529 Fallopia multiflora Species 0.000 claims description 3
- 240000001341 Reynoutria japonica Species 0.000 claims description 3
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012946 outsourcing Methods 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 241000578422 Graphosoma lineatum Species 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 230000000694 effects Effects 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 9
- 240000008397 Ganoderma lucidum Species 0.000 description 8
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000257646 Clerodendrum cyrtophyllum Species 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- -1 stomach invigorating Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001571736 Lysimachia foenum-graecum Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241001327268 Sorghastrum Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241001123263 Zostera Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提出一种治疗白发的综合药物及其制备方法,包括人参根、何首乌、黄精、补骨脂、丁香、桑椹、苦胆草、白芨根、鱼腥草、臭草、覆盆子果、黑灵芝以及沉香。
Description
技术领域
本发明涉及一种治疗白发的综合药物及其制备方法。
背景技术
随着生活方式急剧变化,竞争日益激烈,人们的生活压力和工作压力越来越大,再加上环境污染加剧,白发的人群逐渐扩大,而且患者年龄逐渐年轻化。早年白发尽管表现形势不同,但引起病变的因素有相同之处,既有先天性遗传因素,也有后天因素,既有生理因素,也有病变因素,其中病理性因素引起的白发最为常见。究其原因,或是精神压力大、精神创伤、精神过度紧张、脑力劳动强度大、失眠多梦引起,或是各种急慢性传染病、各种皮肤病引起,或是内分泌失调、营养失衡所引起。
自古传统中医理就研究认为:“肝主藏血,发为血之余”,“肾主藏精,其华在发”,“心主血脉”,“肺主皮毛”。“脾为气血生化之源”。也就是说头发的生长和色泽变化,与五脏六腑的机能盛衰,阳气精血的温煦濡养息息相关。
其中血热、肾气虚弱、气血衰弱都是造成白发的主要原因。因为头发的营养来源于血,如果头发变白或脱落,多半是因为肝血不足,肾气虚弱,导致身体所需要的营养供之不及且排之不畅,很多人皮肤下出现或大或小的包块肿结而使经络不畅,中医的治疗方法是除了补肝血补肾气,还要去结化瘀。
若脏腑机能旺盛,阳气精血充盈,毛发得到充分濡养则黑润秀美,不易脱失。相反,若先天不足,后天失养,脏腑机能虚弱,气血阴阳亏虚,无以充养毛发则白发早生,稀疏易折。这其中与脾、肾、肝的关系尤为密切。凡先天不足、肾精亏虚、髓少失充者,或性情急躁、血热偏盛、伤阴耗血者,或忧愁思虑、脾失健运、气血乏源者,或劳神过度、失眠多梦、肝血暗耗者,皆可伤及五脏,虚损气血,使毛发失养而早白。过早白发导致心情不好,因为白发不但显老不美观,也让人感觉自己生活的不美满。为了掩盖白发,只有去染发,而染发剂是一种含致癌物质的化学品,长时间染发导致很多人过敏、脱发、发质枯干,甚至皮炎的产生等等。严重影响人们的生活质量。
发明内容
为解决上述问题,本发明提出一种治疗白发的综合药物及其制备方法,旨在解决白发问题。
本发明提出一种治疗白发的综合药物,包括人参根、何首乌、黄精、补骨脂、丁香、桑椹、苦胆草、白芨根、鱼腥草、臭草、覆盆子果、黑灵芝以及沉香。
各组分的药效:
人参根:人参的肉质根为强壮滋补药,适用于调整血压、恢复心脏功能、神经衰弱及身体虚弱等症,也有祛痰、健胃、利尿、兴奋等功效。
何首乌:可安神、养血、活络,解毒(截疟)、消痈;制首乌可补益精血、乌须发、强筋骨、补肝肾,是常见贵细中药材。
黄精:是一种味甘辛,性平的药材,有润肺养阴,健脾益气,祛痰止血,消肿解毒的功效,根据《道藏·神仙芝草经》的记载:“肌肉充盛,骨体坚强,其力倍,多年不老,颜色鲜明,发白更黑,齿落更生。
补骨脂:种子入药,有补肾壮阳、补脾健胃之功能,并可治牛皮癣等皮肤病;越南用其酒精浸出液治风湿病;药性:苦、辛、温。归肾、脾经;功效:补肾壮阳,固精缩尿,肾虚腰痛,小便频数,小儿遗尿,肾漏,温脾止泻,纳气平喘。
丁香:《开宝本草》载“丁香味辛温,无毒。主温脾胃,止霍乱,壅胀,风毒诸肿,齿疳,能发诸香。”
桑椹:桑葚入药,始载于唐朝的《唐本草》。中医认为,桑葚味甘性寒,入心肝、肾经,有滋阴补血作用,并能治阴虚津少、失眠等。另据许多古典中医文献记载:利五脏关节,通血气,安魂镇神,降压消渴,令人聪目,变白不老,解中酒毒等功效。现代医学临床证明:桑葚有很好的滋补心、肝、肾,及养血祛风的功效。对降脂和减轻神经衰弱、动脉硬化、性功能衰弱、耳聋眼花、须发早白、内热消渴、血虚便秘、风湿关节疼痛均有显著疗效。美国约翰·佩珠托领导的研究小组的实验发现,桑树含有抗肿瘤物质白藜芦醇,有抗癌作用。药理研究表明:桑葚入胃能补充胃液的缺乏,促进胃液的消化,入肠能促进肠液分泌,增进胃肠蠕动,因而有补益强壮之功。
苦胆草:穿心莲,中药名。又名春莲秋柳,一见喜,榄核莲、苦胆草、金香草、金耳钩、印度草,苦草等。一年生草本植物,长4~8厘米,宽1~2.5厘米。药用植物,味苦,性寒。有清热解毒、消炎、消肿止痛作用。常用于感冒发热,咽喉肿痛,口舌生疮,顿咳劳嗽,泄泻痢疾,热淋涩痛,痈肿疮疡,蛇虫咬伤。
白芨根:痈肿恶疮败疽伤阴死肌.胃中邪气.贼风鬼击.痱缓不收.除白癣疥虫.结热不消.阴下痿.面上.令人肌滑.止惊邪.血邪.血痢.痫疾.风痹.赤眼.症结.温热疟疾.发背.瘰.肠风.痔.扑损刀箭疮.汤火疮.生肌止痛.止肺血。
鱼腥草:味辛,性寒凉,归肺经。能清热解毒、消肿疗疮、利尿除湿、清热止痢、健胃消食,用治实热、热毒、湿邪、疾热为患的肺痈、疮疡肿毒、痔疮便血、脾胃积热等。现代药理实验表明,本品具有抗菌、抗病毒、提高机体免疫力、利尿等作用。
臭草:药用臭草为植物界芸香科植物芸香(Ruta graveolens L.)的全草,6~7月采收,阴干。性寒,味苦、辛。有祛风,退热,利尿,活血,解毒,消肿之功能。用于感冒发热、风湿骨痛、小儿惊风、小便不利、泄泻、疝气、跌打损伤、热毒疮疡、湿疹。
覆盆子果:覆盆子果实含有相当丰富的维生素A、维生素C、钙、钾、镁等营养元素以及大量纤维。覆盆子能有效缓解心绞痛等心血管疾病,但有时会造成轻微的腹泻。覆盆子果实酸甜可口,有“黄金水果”的美誉。树莓含有丰富的水杨酸、酚酸等物质。水杨酸被称为“天然阿斯匹林”,广泛用于镇痛解热,抗血凝,能有效预防血栓。长期食用树莓,能有效地保护心脏,预防高血压、血管壁粥样硬化、心脑血管脆化破裂等心脑血管疾病,可以固精补肾,明目,治劳倦、虚劳,肝肾气虚恶寒,肾气虚逆咳嗽、痿、消瘅、泄泻、赤白浊。
黑灵芝:黑灵芝被称为灵芝中的极品,对人体保健具有的药用疗效,远比其它种类的灵芝为高。抗肿瘤是黑灵芝最为人熟知的药学作用,有研究表明,黑灵芝所含的营养成分中能够作用于肿瘤防治的主要是灵芝多糖、三萜类化合物以及有机锗,以上成分能够抑制人体内多种肿瘤细胞的生长,并且加速肿瘤细胞的凋亡。黑灵芝的抗癌作用并不是某种化合物单一的作用,而是在人体内形成一个综合的免疫系统,提高人体的免疫力。能够调节免疫:黑灵芝多糖、三萜类化合物、蛋白这三种成分在黑灵芝的免疫调节功能中发挥主要作用。多糖可以促进人体的免疫应答反应,刺激嗜中性粒细胞的吞噬作用,加速功能性细胞因子的分泌,达到调节免疫系统的功能。黑灵芝蛋白则可以调节免疫力。三萜类化合物中的灵芝醇F以及灵芝酮二醇能有效抑制补体激活的经典途径。能够治疗心脑血管疾病:服用灵芝多糖、灵芝三萜等营养物质,可以增强身体免疫力,净化血液,从根本上改善健康状况。抗衰老:对黑灵芝抗衰老作用研究比较多,主要在于抗自由基和调节代谢平衡。生物体所产生的内原性防卫自由基损伤的抗氧化剂或抗氧化剂化酶类物质(如超氧化物歧化酶,SOD)的降低,是人体衰老的一个原因。灵芝自古以来就被认为是延年益寿的佳品,灵芝多糖有显著的拟SOD活性,作用于红细胞,能提高红细胞内SOD的活性,增强机体自由基的清除能力,从而阻止自由基对机体的损伤,防止脂体的过氧化,减少自由基造成的脂质过氧化过程,从而对细胞膜形成保护,达到延缓衰老的功效。
沉香:具有行气止痛,温中止呕,纳气平喘之功效。常用于胸腹胀闷疼痛,胃寒呕吐呃逆,肾虚气逆喘急。
于一个或多个实施例中,各组分配比为人参根10-15%、何首乌10-15%、黄精5-8%、补骨脂5-8%、丁香5-8%、桑椹5-10%、苦胆草5-8%、白芨根10-15%、鱼腥草5-10%、臭草5-8%、覆盆子果10-15%、黑灵芝15-20%、沉香5-8%。
一种治疗白发的综合药物制备方法,具体步骤如下:
S1选取原材料、拆/清外包以及清洗容器:选好原材料、清洗干净个中相关容器及外包,做好生产前准备;
S2按照上述配比量称取上述中药组合物,经振磨破壁粉碎系统进行破壁粉碎,得到中药破壁粉后经过搅拌机搅拌均匀;
S3把中药破壁粉装入80目的纱袋中,每袋1000克,放入不锈钢煮锅中;
S4依次加入5-7倍的纯净水和1.5-2倍30-50%的乙醇后加热;
S5加热不锈钢煮锅至120摄氏度后停止加热,待冷却到30摄氏度或者常温后继续加热;
S6重复S5两次后待最后一次加热冷却至常温,导出液体并用80目纱布过滤,静置48小时后,取上液。
于一个或多个实施例中,所述不锈钢的煮锅通过导热油加热。
于一个或多个实施例中,上述过程不能用铁器装储。
具体地:
将上好的上述中药按比例称重、混合、经破壁分批处理30-50秒,再将所有中药经搅拌机搅拌均匀,再用80目的纱袋按1公斤一袋装好,放入以导热油加热的不锈钢的煮锅中,再加入5-7倍的纯净水,再加入1.5-2倍的浓度为30-50%的乙醇,然后加热,待煮锅内温度达到120度时停止加热,待冷却到30度或常温后又继续加热,重复2次。待最后一次完全冷却至常温后,将液体全部倒出来。再用80目的纱布过滤,静置48小时后,取上清液即可使用。
使用方法:
将初生的零星分布在头上的少量白发拔掉后用棉签沾其稀释液点入白发被拔掉后的毛囊处并稍用力涂摸令吸收,48小时左右不得冲洗。15-30天待其重新长出新发时,极大部份就会变黑;如遇久白之白发,即局部白发数量超过该局部一半的,即拔出来根部见不到毛乳头的白发,要重复多次拔点才能变黑。
本发明的有益效果:通过把人参根、何首乌、黄精、补骨脂、丁香、桑椹、苦胆草、白芨根、鱼腥草、臭草、覆盆子果、黑灵芝以及沉香,破壁混合并加水和乙醇经过多次加热熬煮后取清液,该清液能够补肝血和肾气,祛血热,使得头发有白转黑。
具体实施方式
对本申请方案作进一步描述:
一种治疗白发的综合药物,包括人参根、何首乌、黄精、补骨脂、丁香、桑椹、苦胆草、白芨根、鱼腥草、臭草、覆盆子果、黑灵芝以及沉香。
进一步地,各组分配比为人参根10-15%、何首乌10-15%、黄精5-8%、补骨脂5-8%、丁香5-8%、桑椹5-10%、苦胆草5-8%、白芨根10-15%、鱼腥草5-10%、臭草5-8%、覆盆子果10-15%、黑灵芝15-20%、沉香5-8%。
一种治疗白发的综合药物制备方法,具体步骤如下:
S1选取原材料、拆/清外包以及清洗容器:选好原材料、清洗干净个中相关容器及外包,做好生产前准备;
S2按照上述配比量称取上述中药组合物,经振磨破壁粉碎系统进行破壁粉碎,得到中药破壁粉后经过搅拌机搅拌均匀;
S3把中药破壁粉装入80目的纱袋中后放入不锈钢煮锅中;
S4依次加入50-70倍的纯净水和15-20倍30-50%的乙醇后加热;
S5加热不锈钢煮锅至120摄氏度后停止加热,待冷却到30摄氏度或者常温后继续加热;
S6重复S5两次后待最后一次加热冷却至常温,导出液体并用80目纱布过滤,静置48小时后,取上液。
进一步地,所述不锈钢的煮锅通过导热油加热。
进一步地,上述过程不能用铁器装储。
病例一:
病例二:
上述优选实施方式应视为本申请方案实施方式的举例说明,凡与本申请方案雷同、近似或以此为基础作出的技术推演、替换、改进等,均应视为本专利的保护范围。
Claims (5)
1.一种治疗白发的综合药物,其特征在于,包括人参根、何首乌、黄精、补骨脂、丁香、桑椹、苦胆草、白芨根、鱼腥草、臭草、覆盆子果、黑灵芝以及沉香。
2.根据权利要求1所述的治疗白发的综合药物,其特征在于,各组分配比为人参根10-15%、何首乌10-15%、黄精5-8%、补骨脂5-8%、丁香5-8%、桑椹5-10%、苦胆草5-8%、白芨根10-15%、鱼腥草5-10%、臭草5-8%、覆盆子果10-15%、黑灵芝15-20%、沉香5-8%。
3.一种治疗白发的综合药物制备方法,其特征在于,具体步骤如下:
S1选取原材料、拆/清外包以及清洗容器:选好原材料、清洗个中相关容器及外包,做好生产前准备;
S2按照上述配比量称取上述中药组合物,经振磨破壁粉碎系统进行破壁粉碎,得到中药破壁粉后经过搅拌机搅拌均匀;
S3把中药破壁粉装入80目的纱袋中,每1000克为一袋,放入不锈钢煮锅中;
S4依次加入5-7倍的纯净水和1.5-2倍30-50%的乙醇后加热;
S5加热不锈钢煮锅至120摄氏度后停止加热,待冷却到30摄氏度或者常温后继续加热;
S6重复S5两次后待最后一次加热冷却至常温,导出液体并用80目纱布过滤,静置48小时后,取上清液。
4.根据权利要求3所述的治疗白发的综合药物制备方法,其特征在于,所述不锈钢的煮锅通过导热油加热。
5.根据权利要求3所述的治疗白发的综合药物制备方法,其特征在于,上述过程不能用铁器装储。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110433501.9A CN112933182A (zh) | 2021-04-19 | 2021-04-19 | 一种治疗白发的综合药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110433501.9A CN112933182A (zh) | 2021-04-19 | 2021-04-19 | 一种治疗白发的综合药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112933182A true CN112933182A (zh) | 2021-06-11 |
Family
ID=76233196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110433501.9A Pending CN112933182A (zh) | 2021-04-19 | 2021-04-19 | 一种治疗白发的综合药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112933182A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113350252A (zh) * | 2021-06-24 | 2021-09-07 | 湖南侗秀生物科技有限公司 | 一种可白发养黑的中药提取液及制备工艺和设备 |
-
2021
- 2021-04-19 CN CN202110433501.9A patent/CN112933182A/zh active Pending
Non-Patent Citations (1)
Title |
---|
刘青: "《大道无形:121种内外保养法》", 31 October 2011, 中国中医药出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113350252A (zh) * | 2021-06-24 | 2021-09-07 | 湖南侗秀生物科技有限公司 | 一种可白发养黑的中药提取液及制备工艺和设备 |
CN113350252B (zh) * | 2021-06-24 | 2023-07-14 | 湖南侗秀生物科技有限公司 | 一种可白发养黑的中药提取液及制备工艺和设备 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101906376A (zh) | 一种保健醋 | |
CN104856009A (zh) | 一种杜仲雄花保健品 | |
CN102172385A (zh) | 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 | |
CN106620609A (zh) | 一种生发配方及其制备方法 | |
CN107213451A (zh) | 改善人体微循环障碍的益生菌发酵中药制剂及其制备方法 | |
CN111264735A (zh) | 一种扶正固本提高免疫力防控疫毒的功能饮料 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN101700313A (zh) | 内服治疗脱头发的中药组合物 | |
CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
CN112933182A (zh) | 一种治疗白发的综合药物及其制备方法 | |
CN102715509B (zh) | 一种排毒养颜保健品 | |
CN101313992A (zh) | 核桃油软胶囊 | |
CN103190556A (zh) | 具有健胃除湿、清肺化痰作用的新型口含片及其制备方法 | |
CN104856036A (zh) | 治疗缺铁性贫血的保健药膳及制法 | |
CN104825821A (zh) | 一种治疗糖尿病的药物及其制备方法 | |
CN104770519A (zh) | 一种草本凉茶 | |
CN101559191B (zh) | 专治胃癌的纯中药胶囊 | |
CN101313994A (zh) | 用于治疗心房颤动中药胶囊 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN106344759A (zh) | 一种保健品 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN104611180A (zh) | 富硒植物纳米乳保健酒 | |
CN110050934A (zh) | 一种葛根木瓜固态饮料及其制备方法 | |
CN103933409A (zh) | 复方补骨脂黑发软胶丸 | |
CN106434176A (zh) | 具有降三高功能的保健酒及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210611 |